Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether–lumefantrine treatment in Mali

BACKGROUND: Artemisinin-based combination therapy is the recommended first-line treatment for uncomplicated falciparum malaria worldwide. However, recent studies conducted in Mali showed an increased frequency of recurrent parasitaemia following artemether–lumefantrine (AL) treatment. METHODS: Study...

Descripción completa

Detalles Bibliográficos
Autores principales: Dama, Souleymane, Niangaly, Hamidou, Ouattara, Amed, Sagara, Issaka, Sissoko, Sekou, Traore, Oumar Bila, Bamadio, Amadou, Dara, Niawanlou, Djimde, Moussa, Alhousseini, Mohamed Lamine, Goita, Siaka, Maiga, Hamma, Dara, Antoine, Doumbo, Ogobara K., Djimde, Abdoulaye A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289056/
https://www.ncbi.nlm.nih.gov/pubmed/28148267
http://dx.doi.org/10.1186/s12936-017-1700-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289056/
https://www.ncbi.nlm.nih.gov/pubmed/28148267
http://dx.doi.org/10.1186/s12936-017-1700-8

Ejemplares similares